Weise M, Prüfer D, Jaques G, Keller M, Mondorf A W
Contrib Nephrol. 1981;24:88-98. doi: 10.1159/000395233.
Urinary excretion of the low molecular weight protein beta 2-microglobulin and tubular enzymes--alanine aminopeptidase (AAP), gamma-glutamyl transpeptidase (gamma-GT) and alkaline phosphatase (AP)--are very sensitive parameters for proximal tubular lesions. In patients with preeclampsia the renal excretion of beta 2-microglobulin allows to differentiate between a primary preeclampsia and a preeclampsia superimposed upon chronic pyelonephritis. In the first group the increase is 3- to 4-fold and in the second group up to 300-fold. In patients with kidney transplantation the urinary excretion of beta 2-microglobulin, AAP, gamma-GT and AP are several times higher than in normals. In case of a rejection episode a further increase of these proteins occur in more than 80% several days before clinical symptoms are present. The application of analgetics (paracetamol, acetylsalicylic acid) in healthy individuals in therapeutical dosages on 3 consecutive days does not show any tubular alteration by the measurement of urinary beta 2-microglobulin. Aminoglycosides (tobramycin, UK 18,892) lead to a cumulative increase of the renal excretion of beta 2-microglobulin and AAP while cephalosporins induce an increase of total proteins in the final urine under the same conditions.
低分子量蛋白质β2-微球蛋白以及肾小管酶——丙氨酸氨基肽酶(AAP)、γ-谷氨酰转肽酶(γ-GT)和碱性磷酸酶(AP)的尿排泄量,是近端肾小管病变非常敏感的指标。在先兆子痫患者中,β2-微球蛋白的肾脏排泄量有助于区分原发性先兆子痫和叠加于慢性肾盂肾炎之上的先兆子痫。在第一组中,其增加为3至4倍,而在第二组中则高达300倍。在肾移植患者中,β2-微球蛋白、AAP、γ-GT和AP的尿排泄量比正常人高出数倍。在发生排斥反应时,在临床症状出现前数天,超过80%的患者这些蛋白质会进一步增加。连续3天以治疗剂量对健康个体应用镇痛药(对乙酰氨基酚、乙酰水杨酸),通过检测尿β2-微球蛋白未显示出任何肾小管改变。氨基糖苷类药物(妥布霉素、UK 18,892)会导致β2-微球蛋白和AAP的肾排泄量累积增加,而在相同条件下头孢菌素会使终尿中的总蛋白增加。